TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response

被引:65
|
作者
Zeng, Zexian [1 ,2 ]
Wong, Cheryl J. [1 ,3 ]
Yang, Lin [1 ]
Ouardaoui, Nofal [1 ]
Li, Dian [1 ]
Zhang, Wubing [1 ,4 ]
Gu, Shengqing [1 ,2 ,5 ,6 ]
Zhang, Yi [1 ,2 ]
Liu, Yang [1 ]
Wang, Xiaoqing [1 ,2 ,5 ,6 ]
Fu, Jingxin [5 ,7 ]
Zhou, Liye [5 ]
Zhang, Boning [1 ,2 ,5 ,6 ]
Kim, Sarah [7 ]
Yates, Kathleen B. [7 ,8 ]
Brown, Myles [5 ,6 ]
Freeman, Gordon J. [5 ]
Uppaluri, Ravindra [5 ,9 ]
Manguso, Robert [7 ,8 ]
Liu, X. Shirley [1 ,2 ,6 ]
机构
[1] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02215 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA
[3] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA
[4] Tongji Univ, Sch Life Sci & Technol, Shanghai 200060, Peoples R China
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[6] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA
[7] Broad Inst Harvard & MIT, Boston, MA 02129 USA
[8] Massachusetts Gen Hosp, Ctr Canc Res, Harvard Med Sch, Charlestown, MA 02114 USA
[9] Brigham & Womens Hosp, Dept Surg, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
MTB;
D O I
10.1093/nar/gkab804
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Syngeneic mouse models are tumors derived from murine cancer cells engrafted on genetically identical mouse strains. They are widely used tools for studying tumor immunity and immunotherapy response in the context of a fully functional murine immune system. Large volumes of syngeneic mouse tumor expression profiles under different immunotherapy treatments have been generated, although a lack of systematic collection and analysis makes data reuse challenging. We present Tumor Immune Syngeneic MOuse (TISMO), a database with an extensive collection of syngeneic mouse model profiles with interactive visualization features. TISMO contains 605 in vitro RNA-seq samples from 49 syngeneic cancer cell lines across 23 cancer types, of which 195 underwent cytokine treatment. TISMO also includes 1518 in vivo RNA-seq samples from 68 syngeneic mouse tumor models across 19 cancer types, of which 832 were from immune checkpoint blockade (ICB) studies. We manually annotated the sample metadata, such as cell line, mouse strain, transplantation site, treatment, and response status, and uniformly processed and quality-controlled the RNA-seq data. Besides data download, TISMO provides interactive web interfaces to investigate whether specific gene expression, pathway enrichment, or immune infiltration level is associated with differential immunotherapy response. TISMO is available at http://tismo.cistrome.org.
引用
收藏
页码:D1391 / D1397
页数:7
相关论文
共 50 条
  • [41] EFFECT OF EXOGENOUS RNA ON IMPROVEMENT OF SYNGENEIC TUMOR IMMUNITY
    RIGBY, PG
    CANCER RESEARCH, 1971, 31 (01) : 4 - &
  • [42] Cancer Epigenetics, Tumor Immunity, and Immunotherapy
    Cao, Jian
    Yan, Qin
    TRENDS IN CANCER, 2020, 6 (07): : 580 - 592
  • [43] Vascular Microenvironment, Tumor Immunity and Immunotherapy
    Lamplugh, Zachary
    Fan, Yi
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] The effects of Wnt inhibition on tumor progression and the tumor microenvironment in a syngeneic mouse model of ovarian cancer.
    Goldsberry, Whitney
    Doo, David W.
    Meza-Perez, Selene
    Katre, Ashwini A.
    Norian, Lyse
    Randall, Troy
    Arend, Rebecca Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Mouse Models of Tumor Immunotherapy
    Ngiow, Shin Foong
    Loi, Sherene
    Thomas, David
    Smyth, Mark J.
    TUMOR IMMUNOLOGY, 2016, 130 : 1 - 24
  • [46] Circular RNAs in tumor immunity and immunotherapy
    Zhang, Wenjie
    Xu, Chen
    Yang, Zhipeng
    Zhou, Jingshi
    Peng, Wei
    Zhang, Xuan
    Li, Haimin
    Qu, Shibin
    Tao, Kaishan
    MOLECULAR CANCER, 2024, 23 (01)
  • [47] PASSIVE IMMUNOTHERAPY WITH SYNGENEIC ANTI-TUMOR SERUM - PASSIVE IMMUNOTHERAPY OF ESTABLISHED TUMORS WITH SYNGENEIC ANTI-TUMOR SERUM IN COMBINATION WITH IMMUNOPOTENTIATORS
    SHINODA, H
    YAMAZAKI, M
    MIZUNO, D
    GANN, 1977, 68 (05): : 567 - 571
  • [48] SECONDARY CELL-MEDIATED CYTOTOXIC RESPONSE TO SYNGENEIC MOUSE TUMOR CHALLENGE
    HOLDEN, HT
    KIRCHNER, H
    HERBERMAN, RB
    JOURNAL OF IMMUNOLOGY, 1975, 115 (02): : 327 - 331
  • [49] DIFFERENTIAL RESPONSE OF TUMOR BEARER AND NORMAL MOUSE SPLEEN-CELLS TO PHA AND SYNGENEIC TUMOR EXTRACTS INVITRO - EFFECT OF XENOGENEIC AND SYNGENEIC SERA
    LAING, CA
    FEDERATION PROCEEDINGS, 1976, 35 (03) : 387 - 387
  • [50] Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
    Flies, Dallas B.
    Langermann, Solomon
    Jensen, Christina
    Karsdal, Morten A.
    Willumsen, Nicholas
    FRONTIERS IN IMMUNOLOGY, 2023, 14